You are about to go to a website sponsored by Amgen. Would you like to continue?
You will be going to an external website operated by an independent third party. Your activities at the external website will be managed by their policies and practices. By clicking “Continue,” you will go to the external website.
X-linked CGD is an inherited disorder caused by a mutation in the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase complex, which is part of neutrophils and the mechanism to kill pathogens.1
The dihydrorhodamine (DHR) test can help distinguish X-linked CGD and evaluate the risk of infection in X-linked carriers. See why it is the most common test for diagnosing CGD.
X-linked CGD accounts for approximately 65% of CGD cases.2 X-linked CGD often presents early in life with most cases diagnosed by age 5.1
X-linked carriers who experienced severe infections had at least 1 case of pneumonia caused by a common CGD-associated pathogen.4
48% of all X-linked carriers of CGD reported infections, autoimmune symptoms, or both.4
For more information on identifying, testing, and monitoring carriers of X-linked CGD, please review this brochure.
Based on a 2018 study analyzing 93 X-linked carriers of CGD.4
1. Leiding JW, Holland SM. Chronic granulomatous disease. In: Pagon RA, Adam MP, Ardinger HH, et al, eds. GeneReviews®. Seattle, WA: University of Washington, Seattle; 1993-2022. 2. Rider NL, Jameson MB, Creech CB. Chronic granulomatous disease: epidemiology, pathophysiology, and genetic basis of disease. J Pediatric Infect Dis Soc. 2018;7(suppl 1):S2-S5. 3. Noack D, Rae J, Cross AR, et al. Autosomal recessive chronic granulomatous disease caused by defects in NCF-1, the gene encoding the phagocyte p47-phox: mutations not arising in the NCF-1 pseudogenes. Blood. 2001;97(1):305-311. 4. Marciano BE, Zerbe CS, Falcone EL, et al. X-linked carriers of chronic granulomatous disease: illness, lyonization, and stability. J Allergy Clin Immunol. 2018;141(1):365-371.